Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease

Clinical trial NCT07704190 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07704190
Sponsor: Peking University Third Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiorenal Metabolic Syndrome Atherosclerotic Cardiovascular Disease Chronic Kidney Disease Coronary Artery Disease Hypertension Type 2 Diabetes Mellitus Peripheral Arterial Disease Carotid Artery Stenosis

Start date: 2026-07-15
Primary completion: 2028-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.